34 Supported by research
Adenosine accumulates in the brain and body relative to the number of hours spent awake.
"Adenosine is an incredibly interesting molecule. It exists in the brain and body. It accumulates with the number of hours that you're awake, so the longer you're awake, the more adenosine accumulates." (said at 0:00:15)
The claim accurately reflects the established homeostatic model of sleep drive, in which prolonged wakefulness and metabolic activity lead to extracellular adenosine accumulation, notably in key sleep-regulatory regions such as the basal forebrain and parts of the cortex. However, experimental data from microdialysis studies indicate that this accumulation is region-specific rather than a uniform increase throughout all brain regions or peripheral tissues.
- context: Extracellular adenosine in the human brain during sleep and sleep deprivation: an in vivo … (Sleep 2006) · cited 42x in the literature
"Our observations, along with those in animal studies, indicate that the role of extracellular adenosine in regulating sleep pressure is not a global brain phenomenon but is likely limited to specific basal forebrain areas." (abstract, conclusions, passage verified)
pubmedfull study (doi) - supports: Adenosine, energy metabolism and sleep homeostasis. (Sleep medicine reviews 2011) · cited 320x in the literature
"In the central nervous system (CNS) an increase in neuronal activity enhances energy consumption as well as extracellular adenosine concentrations. In most brain areas high extracellular adenosine concentrations, through A1 adenosine receptors, decrease neuronal activity and thus the need for energy... We have identified a relatively specific area, the basal forebrain (BF), which appears to be central in the regulation/execution of recovery sleep after sleep deprivation (SD), or prolonged wakefulness. Adenosine concentration increases in this area during SD, and this increase induces sleep while prevention of the increase during SD abolishes recovery sleep." (abstract, results, passage verified)
pubmedfull study (doi)
Caffeine works by blocking adenosine receptors in the body and brain.
"caffeine... effectively works by blocking the adenosine receptor." (said at 0:01:04)
At dietary and physiologically relevant doses, caffeine acts primarily as a competitive nonselective antagonist of adenosine receptors (most notably A1 and A2A subtypes) in both the central nervous system and peripheral tissues. By binding to these receptors, caffeine blocks endogenous adenosine from exerting its inhibitory and sedative signals, thereby promoting wakefulness, vigilance, and psychomotor arousal.
Adenosine is cleared from the brain and body during sleep.
"when we go to sleep at night, adenosine is cleared from our system." (said at 0:02:04)
Extracellular adenosine acts as a key homeostatic regulator of sleep pressure. Adenosine concentrations progressively increase in brain regions such as the basal forebrain and cortex during sustained wakefulness and are subsequently metabolized and cleared back toward baseline levels during sleep.
Viewing bright light suppresses melatonin levels.
"When you view bright light at night or during the day, and especially in the morning, it quashes those melatonin levels." (said at 0:10:44)
Controlled human experimental trials demonstrate that ocular light exposure exerts acute, dose-dependent suppressive effects on plasma melatonin concentrations.
Specific genetic mutations allow certain individuals to function naturally on only 3 to 5 hours of sleep per night.
"There's—what is it? It's a very small number of people, but there is a genetic mutation that allows certain cohorts to exist on between sort of 3 and 5 hours of sleep, and that's just where they're at." (said at 0:14:50)
Genetic research has identified rare mutations associated with the familial natural short sleep (FNSS) trait. Individuals carrying specific rare variants—such as in DEC2 (BHLHE41), ADRB1, NPSR1, and GRM1—maintain lifelong short sleep durations (typically 4 to 6 hours, and in some individuals down to 3 to 5 hours) without exhibiting the cognitive deficits or adverse health consequences typically caused by sleep deprivation.
The human intrinsic circadian clock generates an intrinsic rhythm of approximately 24.2 or 24.3 hours.
"Your circadian clock, intrinsic to you, generates a 24.2 or a 24.3-hour rhythm—it's not perfectly 24 hours." (said at 0:29:13)
Rigorous human forced-desynchrony and constant-routine laboratory protocols established that the intrinsic period of the human master circadian pacemaker is slightly longer than 24 hours, averaging approximately 24.18 to 24.2 hours across both young and older adults with very tight distribution.
- supports: Stability, precision, and near-24-hour period of the human circadian pacemaker. (Science (New York, N.Y.) 1999) · cited 1710x in the literature
"Precise estimation of the periods of the endogenous circadian rhythms of melatonin, core body temperature, and cortisol in healthy young and older individuals living in carefully controlled lighting conditions has now revealed that the intrinsic period of the human circadian pacemaker averages 24.18 hours in both age groups, with a tight distribution consistent with other species." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Sleep and circadian rhythms in humans. (Cold Spring Harbor symposia on quantitative biology 2007) · cited 419x in the literature
"In sighted humans, the intrinsic circadian period is very tightly distributed around approximately 24.2 hours and exhibits aftereffects of prior entrainment." (abstract, passage verified)
pubmedfull study (doi)
Melatonin is released from the pineal gland.
"melatonin, which is released from the pineal gland, a pea-sized gland sort of deep in the vestiges of your brain." (said at 0:11:04)
Melatonin is a well-established neurohormone synthesized and secreted primarily by the pineal gland in a circadian pattern governed by the suprachiasmatic nucleus, with secretion stimulated by darkness and suppressed by light.
Genetic polymorphisms cause certain individuals to be natural night owls with delayed sleep phases.
"So there are genetic mutations, they call them polymorphisms, that make some people night owls. They feel best psychologically and physically going to sleep at about 1:00, 2:00, or 3:00 a.m. and waking up somewhere around, you know, 10:00, 11:00 a.m. or noon." (said at 0:24:35)
Large-scale genome-wide association studies and monogenic pedigree analyses demonstrate that genetic variations and polymorphisms directly influence chronotype and delayed sleep phases. A landmark GWAS of 697,828 individuals identified 351 genetic loci enriched in circadian regulation pathways that associate with natural morningness versus eveningness and objectively measured sleep timing. Additionally, specific coding variants in core circadian clock genes—such as a dominant mutation in CRY1 that lengthens the period of the circadian molecular oscillator—cause familial delayed sleep phase disorder (DSPD), resulting in substantially delayed sleep-wake schedules.
- supports: Mutation of the Human Circadian Clock Gene CRY1 in Familial Delayed Sleep Phase Disorder. (Cell 2017) · cited 384x in the literature
"Here, we report a hereditary form of DSPD associated with a dominant coding variation in the core circadian clock gene CRY1, which creates a transcriptional inhibitor with enhanced affinity for circadian activator proteins Clock and Bmal1. This gain-of-function CRY1 variant causes reduced expression of key transcriptional targets and lengthens the period of circadian molecular rhythms, providing a mechanistic link to DSPD symptoms." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Genome-wide association analyses of chronotype in 697,828 individuals provides insights in… (Nature communications 2019) · cited 741x in the literature
"Using genome-wide data from 697,828 UK Biobank and 23andMe participants we increase the number of genetic loci associated with being a morning person from 24 to 351. Using data from 85,760 individuals with activity-monitor derived measures of sleep timing we find that the chronotype loci associate with sleep timing: the mean sleep timing of the 5% of individuals carrying the most morningness alleles is 25 min earlier than the 5% carrying the fewest." (abstract, results, passage verified)
pubmedfull study (doi)
There is a direct neural pathway from the brainstem to the suprachiasmatic nucleus that entrains the circadian clock in response to exercise.
"In the case of exercise, there's literally a brain stem to circadian clock connection, a big superhighway of neuronal connection that then so-called entrains your circadian clock." (said at 0:27:38)
Preclinical evidence supports the existence of a direct serotonergic neural pathway from the midbrain raphe nuclei in the brainstem to the suprachiasmatic nucleus (SCN) of the hypothalamus that mediates exercise/activity-dependent entrainment of the central circadian clock. In rodent models, selectively lesioning these serotonergic terminals prevented scheduled voluntary wheel running from entraining circadian rhythms without altering baseline physical activity. Because this specific neural mechanism of exercise entrainment has been demonstrated in animal models rather than direct human trials, the certainty of evidence is very low.
Viewing bright light between 4:00 p.m. and 10:00 p.m. causes a phase delay in the circadian clock, making an individual want to wake up later the following morning.
"If you want to become a night person, you do the opposite: you view bright light between the hours of 4:00 p.m. and 10:00 p.m., and then you will phase delay or phase shift in a delayed way your circadian clock, making you want to wake up later the next morning." (said at 0:32:06)
Extensive human photobiology and circadian research has established the phase response curve (PRC) to bright light. Light exposure in the late subjective day and early subjective night (such as between late afternoon and late evening, before the core body temperature minimum) produces phase delays in the human circadian clock, shifting the circadian rhythm of melatonin, body temperature, and the endogenous drive for sleep and wake timing later.
Intrinsically photosensitive retinal ganglion cells that project to the circadian clock are present in every extant mammalian species.
"Intrinsically photosensitive retinal ganglion cells, the ones that project to the clock and carry all of this thing about circadian entrainment to sunlight, are present, as far as we know, in every extant mammalian species—every mammalian species that's alive today." (said at 0:33:20)
Intrinsically photosensitive retinal ganglion cells (ipRGCs) express the photopigment melanopsin (OPN4) and project via the retinohypothalamic tract to the suprachiasmatic nucleus (the master circadian pacemaker) to drive circadian photoentrainment. Comparative neuroanatomical studies and large-scale genomic analyses across mammalian orders—encompassing diurnal, nocturnal, and naturally blind subterranean species (such as blind mole rats)—demonstrate that melanopsin and the retinohypothalamic pathway mediating circadian entrainment are conserved across extant mammalian lineages.
- supports: Evolutionary Constraint on Visual and Nonvisual Mammalian Opsins. (Journal of biological rhythms 2021) · cited 52x in the literature
"Using genomic data from over 400 mammalian species from 22 orders, unique patterns of evolution for each mammalian opsins were identified, including photoisomerases, RGR-opsin (RGR) and peropsin (RRH), as well as atypical opsins, encephalopsin (OPN3), melanopsin (OPN4), and neuropsin (OPN5)... Importantly, all mammalian opsins retain key amino acid residues important for conjugation to retinal-based chromophores, permitting light sensitivity." (abstract, passage verified)
pubmedfull study (doi) - supports: Comparative Neurology of Circadian Photoreception: The Retinohypothalamic Tract (RHT) in S… (Frontiers in neuroscience 2021) · cited 17x in the literature
"The mammalian eye contains two systems for light perception: an image detecting system constituted primarily of the classical photoreceptors, rods and cones, and a non-image forming system (NIF) constituted of a small group of intrinsically photosensitive retinal ganglion cells driven by melanopsin (mRGCs). The mRGCs receive input from the outer retina and NIF mediates light entrainment of circadian rhythms, masking behavior, light induced inhibition of nocturnal melatonin secretion, pupillary reflex (PLR), and affect the sleep/wake cycle. This review focuses on the mammalian NIF and its anatomy in the eye as well as its neuronal projection to the brain. This pathway is known as the retinohypothalamic tract (RHT)." (abstract, passage verified)
pubmedfull study (doi)
Neuroplasticity occurs during sleep, and sleep reduces adenosine levels in the brain.
"Neuroplasticity occurs during sleep, it pushes down adenosine, you know, it takes us through these natural ebbs and cycles of cognition." (said at 0:34:00)
Extensive neurobiological research supports both assertions. Sleep plays a critical role in neuroplasticity, offline memory consolidation, and synaptic homeostasis, during which spontaneous neural activity renormalizes synaptic strength and stabilizes neural circuits. In addition, extracellular adenosine—a somnogenic neuromodulator that accumulates during wakefulness and sleep deprivation (notably in the basal forebrain)—is cleared and restored to baseline levels during recovery sleep.
A review by James McGaugh in the Annual Review of Neuroscience describes a medieval practice where children were given religious tutorials and then thrown into cold water to spike adrenaline and enhance memory retention.
"You know that there's we know, and there's a beautiful review by James McGaugh, one of the leading researchers in memory, about this, that dating back to medieval times, if they wanted kids to remember something, I'm not making this up, in an Annual Review of Neuroscience, it starts off by describing they would take kids, they'd give them a tutorial—typically, it was a religious tutorial back then—then they'd throw them into cold water so you got a spike in adrenaline, and then you'd remember what you had heard prior." (said at 0:37:56)
The claim accurately describes the introductory premise and neurobiological findings reviewed by memory neurobiologist James L. McGaugh. In his influential review in the Annual Review of Neuroscience (2004, 27:1–28), McGaugh begins by describing the historical practice from past centuries of throwing young boys into rivers (or inflicting sudden pain) immediately after witnessing an important event or lesson to ensure they would retain long-term memory of it. McGaugh's review and subsequent papers detail how acute post-learning emotional arousal triggers adrenal stress hormones (epinephrine/adrenaline and glucocorticoids) acting on the basolateral amygdala to enhance memory consolidation.
Exposure to even small amounts of bright artificial light between approximately 9:30 p.m. and 4:00 a.m. suppresses melatonin secretion and impairs sleep quality.
"it requires just a little bit of bright light, even from an artificial source, after the hours of about 9:30 p.m. till 4:00 a.m. to quash your melatonin, make it difficult to sleep, or if you sleep, to make that sleep not as effective." (said at 0:30:16)
Extensive controlled human experimental evidence and systematic reviews confirm that exposure to artificial light during evening and nighttime hours suppresses melatonin secretion, delays circadian timing, increases sleep latency, and impairs sleep quality and alertness. Dose-response studies show that the human circadian system is sensitive to relatively low levels of evening artificial light, with half-maximal melatonin suppression occurring at approximately 25 lux (and as low as 6 lux in sensitive individuals), which is well below typical indoor lighting (100–300 lux). Controlled trials of light-emitting devices before bedtime similarly show delayed sleep onset, acute melatonin suppression, and reduced sleep effectiveness.
- supports: Evening use of light-emitting eReaders negatively affects sleep, circadian timing, and nex… (Proceedings of the National Academy of Sciences of the United States of America 2015) · cited 1414x in the literature
"Participants reading an LE-eBook took longer to fall asleep and had reduced evening sleepiness, reduced melatonin secretion, later timing of their circadian clock, and reduced next-morning alertness than when reading a printed book." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Systematic review of light exposure impact on human circadian rhythm. (Chronobiology international 2019) · cited 476x in the literature
"Light exposure in the evening, at night and in the morning affected the circadian phase of melatonin levels. In addition, even the longest wavelengths (631 nm, red) and intermittent light exposures induced circadian resetting responses, and exposure to low light levels (5-10 lux) at night when sleeping with eyes closed induced a circadian response." (abstract, results, passage verified)
pubmedfull study (doi) - supports: High sensitivity and interindividual variability in the response of the human circadian sy… (Proceedings of the National Academy of Sciences of the United States of America 2019) · cited 434x in the literature
"The group-level fitted ED 50 was 24.60 lux, indicating that the circadian system is highly sensitive to evening light at typical indoor levels. Light intensities of 10, 30, and 50 lux resulted in later apparent melatonin onsets by 22, 77, and 109 min, respectively." (abstract, results, passage verified)
pubmedfull study (doi)
MDMA recently failed to receive FDA approval for the treatment of PTSD.
"MDMA, which just recently, day before yesterday, failed to pass approval by the FDA for the treatment of PTSD." (said at 1:01:11)
In 2024, the US Food and Drug Administration (FDA) rejected the New Drug Application (NDA) for MDMA-assisted therapy (submitted by Lykos Therapeutics) for the treatment of post-traumatic stress disorder (PTSD), requesting an additional phase 3 clinical trial due to concerns over study design (such as functional unblinding), safety evaluations, and data integrity.
During rapid eye movement (REM) sleep, skeletal muscle is paralyzed while the brain remains active.
"And if you think about rapid eye movement sleep, which is the most dream-rich sleep, your body is paralyzed and the mind is active." (said at 1:14:22)
Rapid eye movement (REM) sleep—also termed paradoxical sleep—is characterized by wake-like, desynchronized cortical electroencephalogram (EEG) patterns indicating active cerebral processing alongside active motor inhibition (muscle atonia) of somatic skeletal musculature, mediated by descending brainstem and spinal circuits.
Psychologist Erik Erikson posited that human development consists of core psychosocial conflicts worked out at distinct stages from birth until death.
"And the great psychologist Erikson talked about at every stage of life, from birth until death, until one's 80s and 90s, you're working out some core conflicts of agency versus autonomy versus having to do what other people have you do." (said at 1:18:55)
Erik Erikson's landmark framework of psychosocial development posits that individuals progress through a series of developmental stages across the entire lifespan, from birth through old age (80s and 90s). At each stage, individuals encounter a primary psychosocial conflict or crisis—such as Autonomy versus Shame and Doubt in early childhood, or Integrity versus Despair in late adulthood—that must be navigated to foster psychological growth.
Carrying two copies of a genetic mutation causing adrenal androgen overproduction (such as non-classical congenital adrenal hyperplasia) can cause infertility, whereas heterozygosity (carrying one copy) causes androgen overproduction without causing infertility.
"I'm a heterozygote for a certain genetic mutation: I overproduce androgen from my adrenals. If you have two copies, it can make you infertile; fortunately, I don't, I have one copy, and it doesn't result in any other bodily differences or anything like that." (said at 1:25:06)
Biallelic pathogenic variants in CYP21A2 cause 21-hydroxylase deficiency (classic or non-classic congenital adrenal hyperplasia [CAH]), which leads to adrenal androgen excess that frequently causes subfertility or infertility in women due to chronic anovulation and elevated progesterone levels. In contrast, monoallelic (heterozygous) carriers often exhibit mild adrenal steroidogenic abnormalities, including intermediate elevations in basal or ACTH-stimulated adrenal androgen and precursor levels (such as 17-hydroxyprogesterone), generally without severe phenotypic consequences or frank infertility.
- supports: Congenital adrenal hyperplasia because of 21-hydroxylase deficiency. A genetic disorder of… (Obstetrical & gynecological survey 2009) · cited 45x in the literature
"In women with CAH, hyperandrogenism may be present, extending from virilization of external genitalia and salt-wasting in classical (C)-CAH cases, to menstrual irregularity, obesity, short stature, infertility or subfertility and skin disorders such as hirsutism, in nonclassical (NC)-CAH cases." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Clinical and hormonal characteristics in heterozygote carriers of congenital adrenal hyper… (The Journal of steroid biochemistry and molecular biology 2020) · cited 27x in the literature
"The heterozygous carriers of CYP21 mutations are at increased risk of developing clinically evident hyperandrogenism, even though clinical and laboratory characteristics are still underestimated." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Differences in hormonal levels between heterozygous CYP21A2 pathogenic variant carriers, n… (Archives of endocrinology and metabolism 2022) · cited 8x in the literature
"Heterozygous carriers presented higher basal and post-cosyntropin 17-hydroxyprogesterone (17OHP) than wild type individuals (p < 0.05) and lower basal and stimulated 17OHP levels than NC-CAH patients (p < 0.05)." (abstract, results, passage verified)
pubmedfull study (doi)
Andrew Huberman's laboratory published two papers, including a clinical trial, in 2023.
"we published two papers including a clinical trial in 2023" (said at 1:40:25)
In 2023, Andrew Huberman's laboratory published two original research articles in Cell Press journals. This included a remote randomized controlled clinical trial evaluating breathwork exercises versus mindfulness meditation (Balban et al., Cell Reports Medicine, NCT05304000) and a basic neuroscience study examining retinal axon regeneration (Tran et al., Cell Reports).
- supports: Brief structured respiration practices enhance mood and reduce physiological arousal. (Cell reports. Medicine 2023) · cited 277x in the literature
"Here, we report a remote, randomized, controlled study (NCT05304000) of three different daily 5-min breathwork exercises compared with an equivalent period of mindfulness meditation over 1 month." (abstract, methods, passage verified)
pubmedfull study (doi) - supports: Postsynaptic neuronal activity promotes regeneration of retinal axons. (Cell reports 2023) · cited 20x in the literature
"Here, we established a paradigm in which the enhancement of neural activity in the distal optic pathway, where the postsynaptic visual target neurons reside, promotes RGC axon regeneration and target reinnervation and leads to the rescue of optomotor function." (abstract, results, passage verified)
pubmedfull study (doi)
Rapamycin targets mTOR and broadly mimics the biological effects of fasting.
"Rapamycin targets the mTOR, and in some sense mimics fasting." (said at 2:21:57)
Rapamycin is a direct pharmacological inhibitor of the mechanistic target of rapamycin (mTOR), a central nutrient-sensing kinase complex. During fasting or caloric restriction, mTOR signaling is naturally suppressed, leading to downstream biological processes such as autophagy induction, reduced mRNA translation, and metabolic remodeling. Because inhibiting mTOR pharmacologically reproduces key downstream cellular pathways and longevity-associated phenotypes of nutrient deprivation, rapamycin is widely classified and studied as a caloric restriction and fasting mimetic.
Studies across multiple species, including mice, demonstrate that severe caloric restriction significantly extends lifespan.
"Keep in mind that the studies showing extension of life in different species, including mice, show that being fairly dramatically sub-maintenance caloric extends lifespan" (said at 2:22:04)
The claim is supported by extensive laboratory evidence. Caloric restriction (CR) or dietary restriction significantly extends lifespan across multiple diverse model organisms, including yeast, Caenorhabditis elegans, Drosophila, mice, and non-human primates (rhesus monkeys). For example, a 2024 study by Nduhishe et al. evaluating 960 genetically diverse mice demonstrated that 20% and 40% caloric restriction extended lifespan in proportion to the degree of restriction (PMID: 39385029). Similarly, meta-analyses and reviews confirm CR extends lifespan across various taxa (PMID: 23438200, PMID: 12936916), and joint analyses of long-term non-human primate studies demonstrate survival and health benefits in rhesus monkeys (PMID: 28094793).
Severe caloric restriction causes testosterone levels, libido, and fertility to plummet in both men and women.
"I mean, at some point you are sub-caloric enough that testosterone levels plummet in men and women, libido plummets, fertility plummets in men and women." (said at 2:22:26)
Substantial evidence from randomized clinical trials and endocrine literature confirms that severe energy deficit or low energy availability suppresses the hypothalamic-pituitary-gonadal (HPG) axis in both sexes. In controlled clinical trials of energy deficit, total and free testosterone levels significantly decrease in men. Energy deficiency disrupts hypothalamic gonadotropin-releasing hormone (GnRH) pulsatility, diminishing pituitary secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). In females, this leads to functional hypothalamic amenorrhea, hypoestrogenism, and anovulatory infertility. In males, it results in hypogonadotropic hypogonadism with suppressed testosterone levels and impaired reproductive function.
- supports: High protein diets do not attenuate decrements in testosterone and IGF-I during energy def… (Metabolism: clinical and experimental 2014) · cited 18x in the literature
"As compared to WM and regardless of dietary protein intake, total and free testosterone, total IGF-I, and acid-labile subunit decreased (P<0.05), whereas SHBG and IGF binding proteins-1, -2, and -3 increased (P<0.05) during ED." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Relative energy deficiency in sports (RED-S): elucidation of endocrine changes affecting t… (Hormones (Athens, Greece) 2021) · cited 162x in the literature
"Energy deficiency reduces hypothalamic pulsatile release of gonadotropin-releasing hormone, this impairing anterior pituitary release of gonadotropins. In women, reduced FSH and LH pulsatility produces hypoestrogenism, causing functional hypothalamic amenorrhea and decreased bone mass. In men, it reduces testosterone and negatively affects bone health." (abstract, passage verified)
pubmedfull study (doi)
Research indicates that nicotinamide riboside (NR) converts to NAD+ within cells more readily than nicotinamide mononucleotide (NMN).
"and point to the fact that NR has been shown to convert to NAD in cells more readily than NMN." (said at 2:23:44)
Cellular and isotope-tracing studies demonstrate that nicotinamide riboside (NR) is taken up directly into mammalian cells via equilibrative nucleoside transporters (ENTs) to form NAD+, whereas extracellular nicotinamide mononucleotide (NMN)—a phosphorylated nucleotide—generally cannot cross the plasma membrane intact in most cell types. Instead, extracellular NMN must first be dephosphorylated to NR by extracellular enzymes (such as CD73/ecto-5'-nucleotidase) before entering the cell and converting to NAD+, making NR uptake and subsequent intracellular conversion more direct.
Research from Glen Jeffery's laboratory at University College London demonstrates that morning red light therapy can offset age-related vision decline.
"we have the data from Glen Jeffery's lab showing that red light therapy, especially in the early part of the day, may offset some age-related vision decline." (said at 2:26:30)
Research led by Glen Jeffery at University College London has demonstrated that brief exposure to deep red light (670 nm) can improve age-related declines in photoreceptor function in older adults. In human studies, 670 nm light significantly improved tritan (blue) color contrast sensitivity and rod thresholds in individuals aged 40 and older, with subsequent work highlighting that photobiomodulation of mitochondrial ATP production and visual function is most effective when administered during morning hours.
Netrin and ephrin act as chemoattractants and guidance cues during nervous system wiring.
"And indeed, those chemoattractants exist. They go by the names of things like netrin, which means to guide, or ephrin, etc." (said at 2:37:55)
Netrins and ephrins are well-established guidance cues in neural development. Netrins (derived from the Sanskrit 'netr', meaning 'guide' or 'one who guides') act as bifunctional chemotropic cues (functioning as chemoattractants or chemorepellents depending on receptor expression), while ephrins and their Eph receptors provide critical guidance and positional signaling to direct axonal growth cones during nervous system wiring.
Taking hCG maintains sperm production when using exogenous testosterone.
"you need to bank sperm if you want kids, you need to take HCG if you want to maintain sperm production, you need to keep dosages low." (said at 2:47:25)
Clinical studies and reviews support the claim that co-administering human chorionic gonadotropin (hCG) alongside exogenous testosterone therapy maintains intratesticular testosterone and preserves spermatogenesis. Exogenous testosterone alone suppresses luteinizing hormone and follicle-stimulating hormone via negative feedback on the hypothalamic-pituitary-gonadal axis, frequently causing severe oligospermia or azoospermia. Concomitant low-dose hCG acts as an LH analog, stimulating Leydig cells to maintain the intratesticular testosterone levels required for continued sperm production.
Animal studies show BPC-157 promotes fibroblast recruitment and tissue repair in models of Achilles tendon rupture and sciatic nerve injury.
"Here's what we know about BPC-157: it's from the animal studies, it seems able to detect injury in some very interesting way and lead to fibroblasts, a certain kind of cell type relevant to tendon, etc. ... It's actual Achilles tendon ruptures in the mice or the rats that they're using, right? ... And sciatic nerve as well." (said at 2:47:57)
Animal and in vitro studies support the claim. In rat models of Achilles tendon transection, administration of BPC-157 significantly promoted tendon fibroblast outgrowth, migration, survival under oxidative stress, collagen formation, and functional/biomechanical recovery. Similarly, in rat models of sciatic nerve transection, BPC-157 accelerated axonal regeneration, improved nerve conduction and functional recovery, and enhanced tissue healing. Because the evidence is derived exclusively from preclinical rodent and in vitro models, the certainty of evidence for translational human clinical efficacy remains very low.
- supports: Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and… (Journal of orthopaedic research : official publication of the Orthopaedic Research Society 2003) · cited 70x in the literature
"In comparison, pentadecapeptide BPC 157 fully improves recovery: (i) biomechanically, increased load of failure, load of failure per area and Young's modulus of elasticity; (ii) functionally, significantly higher AFI-values; (iii) microscopically, more mononuclears and less granulocytes, superior formation of fibroblasts, reticulin and collagen; (iv) macroscopically, smaller size and depth of tendon defect, and subsequently the reestablishment of full tendon integrity." (abstract, results, passage verified)
pubmedfull study (doi) - supports: Peptide therapy with pentadecapeptide BPC 157 in traumatic nerve injury. (Regulatory peptides 2010) · cited 42x in the literature
"We focused on the healing of rat transected sciatic nerve and improvement made by stable gastric pentadecapeptide BPC 157 (10 microg, 10ng/kg) applied shortly after injury ... Thus, BPC 157 markedly improved rat sciatic nerve healing." (abstract, results and conclusions)
pubmedfull study (doi) - supports: The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrow… (Journal of applied physiology (Bethesda, Md. : 1985) 2011) · cited 109x in the literature
"BPC 157 markedly increased the in vitro migration of tendon fibroblasts in a dose-dependent manner as revealed by transwell filter migration assay. ... In conclusion, BPC 157 promotes the ex vivo outgrowth of tendon fibroblasts from tendon explants, cell survival under stress, and the in vitro migration of tendon fibroblasts, which is likely mediated by the activation of the FAK-paxillin pathway." (abstract, results and conclusions)
pubmedfull study (doi)
Glaucoma is the second leading cause of blindness in the world, second only to cataracts.
"trying to understand and cure glaucoma, the second leading cause of blindness in the world, second only to cataracts." (said at 2:59:46)
Global epidemiological analyses from the Vision Loss Expert Group and the Global Burden of Disease Study confirm that cataract is the leading cause of blindness globally, and glaucoma is the second leading cause (and the leading cause of irreversible blindness).
Cerebrolysin is marketed and sold in Europe, but is not approved for sale in the United States.
"Cerebrolysin, which is sold in Europe, but not the US." (said at 2:39:06)
Cerebrolysin (a porcine brain-derived peptide preparation produced primarily in Austria) is authorized and marketed in numerous European and international countries for conditions such as stroke, traumatic brain injury, and dementia, but it is not approved by the U.S. Food and Drug Administration (FDA) for clinical sale or use in the United States.
Anorexia nervosa has the highest mortality rate of all psychiatric disorders.
"anorexia nervosa, the most deadly of all psychiatric illnesses, period." (said at 5:04:24)
Systematic reviews and meta-analyses of longitudinal cohort studies demonstrate that anorexia nervosa (AN) carries one of the highest premature mortality rates and standardized mortality ratios (SMRs) of any psychiatric disorder. A landmark meta-analysis of 36 studies reported a weighted SMR of 5.86 for anorexia nervosa, significantly higher than for other eating disorders and major psychiatric illnesses, with deaths resulting from both medical complications (such as cardiac failure) and suicide. Subsequent updated meta-analyses continue to confirm pooled SMRs between 5.06 and 5.21 for AN.
- supports: Mortality rates in patients with anorexia nervosa and other eating disorders. A meta-analy… (Archives of general psychiatry 2011) · cited 2872x in the literature
"The weighted mortality rates (ie, deaths per 1000 person-years) were 5.1 for AN, 1.7 for BN, and 3.3 for EDNOS. The standardized mortality ratios were 5.86 for AN, 1.93 for BN, and 1.92 for EDNOS. One in 5 individuals with AN who died had committed suicide. Individuals with eating disorders have significantly elevated mortality rates, with the highest rates occurring in those with AN." (abstract, results and conclusions, passage verified)
pubmedfull study (doi) - supports: Systematic Review and Meta-Analysis of Mortality in Patients With Anorexia Nervosa. (The International journal of eating disorders 2026) · cited 7x in the literature
"Anorexia nervosa (AN) has one of the highest mortality rates among psychiatric disorders. This systematic review and meta-analysis examined the all-cause mortality of AN patients compared to the general population using the standardized mortality ratio (SMR)... The pooled SMR from 22 studies was 5.06 (95% CI [3.47-7.38]). Suicide and cardiac deaths accounted for 21% and 19% of deaths, respectively." (abstract, background and results, passage verified)
pubmedfull study (doi)
Human rod photoreceptors in the retina are capable of detecting a single photon of light.
"one that is the rod system, which is very sensitive, it's the one you use at dusk and at night to sense if there's anything in your environment. It's very sensitive, it can detect one photon, one photon, but it has very poor acuity." (said at 5:12:38)
Physiological and psychophysical research confirms that human rod photoreceptors respond reliably to individual photons of light and that human subjects can report single-photon stimuli significantly above chance levels. Single-cell electrophysiological recordings of primate photoreceptors demonstrate that rod cells generate a distinct, stereotyped electrical signal in response to a single photon. Furthermore, behavioral studies utilizing quantum single-photon light sources have confirmed that humans are capable of perceiving single-photon inputs incident on the eye.
- supports: Direct detection of a single photon by humans. (Nature communications 2016) · cited 193x in the literature
"Rod cells respond to individual photons, yet whether a single-photon incident on the eye can be perceived by a human subject has remained a fundamental open question. Here we report that humans can detect a single-photon incident on the cornea with a probability significantly above chance." (abstract, passage verified)
pubmedfull study (doi) - supports: Photoreceptor signals and vision. Proctor lecture. (Investigative ophthalmology & visual science 1987) · cited 293x in the literature
"Analysis of the response properties and dark noise of primate rods gives a physiological basis for several fundamental features of human rod vision: single photon detection, poor temporal resolution, the "dark light," rod saturation, scotopic spectral sensitivity, and, perhaps, after-image signals." (abstract, passage verified)
pubmed
Dogs possess dichromatic vision, possessing two types of cone photoreceptors, unlike trichromatic humans.
"dogs see this probably as kind of a blunted orange or a burnt orange because they are dichromats, not trichromats." (said at 5:13:10)
Electrophysiological and behavioral studies confirm that dogs possess dichromatic color vision based on two classes of cone photoreceptors (short-wavelength-sensitive cones peaking at approximately 429-435 nm and long/medium-wavelength-sensitive cones peaking at approximately 555 nm), unlike the trichromatic visual system of normal humans.
Creatine monohydrate supplementation does not damage kidney function and supports cognitive performance.
"Turns out doesn't destroy your kidneys, okay. It's also good for cognition, it turns out." (said at 5:20:54)
Systematic reviews and meta-analyses of randomized controlled trials support both assertions. Regarding kidney function, meta-analyses demonstrate that while creatine supplementation can lead to a slight increase in serum creatinine levels (due to increased metabolic turnover of creatine into creatinine), it causes no significant alterations in actual renal filtration markers such as glomerular filtration rate (GFR), estimated GFR (eGFR), or serum urea. Regarding cognitive performance, meta-analyses of randomized trials show that creatine supplementation significantly improves aspects of cognitive function, particularly memory performance, processing speed, and attention, with pronounced benefits observed in older adults and populations experiencing metabolic stress.
- supports: Effects of creatine supplementation on memory in healthy individuals: a systematic review … (Nutrition reviews 2023) · cited 69x in the literature
"Overall, creatine supplementation improved measures of memory compared with placebo (standard mean difference [SMD] = 0.29, 95%CI, 0.04-0.53; I2 = 66%; P = 0.02)." (abstract, results, passage verified)
pubmedfull study (doi) - supports: The effects of creatine supplementation on cognitive function in adults: a systematic revi… (Frontiers in nutrition 2024) · cited 40x in the literature
"Current evidence suggests that creatine monohydrate supplementation may confer beneficial effects on cognitive function in adults, particularly in the domains of memory, attention time, and information processing speed." (abstract, conclusions, passage verified)
pubmedfull study (doi) - supports: Effect of creatine supplementation on kidney function: a systematic review and meta-analys… (BMC nephrology 2025) · cited 14x in the literature
"Creatine supplementation is associated with a modest, transient increase in serum creatinine levels, likely due to metabolic turnover rather than renal impairment. No significant changes were observed in GFR, suggesting preserved kidney function." (abstract, conclusions, passage verified)
pubmedfull study (doi) - supports: The effect of creatine supplementation on kidney function: a systematic review and meta-an… (Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation 2026) · cited 1x in the literature
"There was neither a difference in urea concentrations (MD = -0.60 mg/dL; 95% CI: -2.15 to 0.96, n=12), nor in eGFR values (MD = -5.20 mL/min/1.73 m 2 ; 95% CI: -15.00 to 4.60, n=8) between the two groups." (abstract, results, passage verified)
pubmedfull study (doi)
The BRAIN Initiative infused over $100 million into brain research when launched during the Obama administration.
"during the Obama administration, there was the BRAIN Initiative. It infused over $100 million into brain research." (said at 5:02:19)
The Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative was officially launched by President Barack Obama on April 2, 2013, with an initial federal investment proposed at approximately $100 million for Fiscal Year 2014 across federal agencies including the National Institutes of Health (NIH), Defense Advanced Research Projects Agency (DARPA), and National Science Foundation (NSF). Funding grew substantially in subsequent fiscal years.
Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.